Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0000255 |
IMP |
allantoin metabolic process |
GO:0000979 |
IDA |
RNA polymerase II core promoter sequence-specific DNA binding |
GO:0001553 |
IGI |
luteinization |
GO:0001779 |
IGI |
natural killer cell differentiation |
GO:0003677 |
IDA |
DNA binding |
GO:0003682 |
ISS |
chromatin binding |
GO:0004871 |
IGI |
signal transducer activity |
GO:0005509 |
IEA |
calcium ion binding |
GO:0005515 |
IPI |
protein binding |
GO:0005634 |
IDA |
nucleus |
GO:0005654 |
TAS |
nucleoplasm |
GO:0005737 |
IDA |
cytoplasm |
GO:0005829 |
TAS |
cytosol |
GO:0006101 |
IMP |
citrate metabolic process |
GO:0006103 |
IMP |
2-oxoglutarate metabolic process |
GO:0006105 |
IMP |
succinate metabolic process |
GO:0006107 |
IMP |
oxaloacetate metabolic process |
GO:0006357 |
IGI |
regulation of transcription from RNA polymerase II promoter |
GO:0006549 |
IMP |
isoleucine metabolic process |
GO:0006573 |
IMP |
valine metabolic process |
GO:0006600 |
IMP |
creatine metabolic process |
GO:0006631 |
IMP |
fatty acid metabolic process |
GO:0007259 |
IDA |
JAK-STAT cascade |
GO:0007548 |
IMP |
sex differentiation |
GO:0007565 |
IGI |
female pregnancy |
GO:0007595 |
IMP |
lactation |
GO:0008284 |
IGI |
positive regulation of cell proliferation |
GO:0019218 |
IGI |
regulation of steroid metabolic process |
GO:0019221 |
IDA |
cytokine-mediated signaling pathway |
GO:0019530 |
IMP |
taurine metabolic process |
GO:0019903 |
IPI |
protein phosphatase binding |
GO:0019915 |
IGI |
lipid storage |
GO:0030155 |
IMP |
regulation of cell adhesion |
GO:0030856 |
IMP |
regulation of epithelial cell differentiation |
GO:0032819 |
IMP |
positive regulation of natural killer cell proliferation |
GO:0032825 |
IMP |
positive regulation of natural killer cell differentiation |
GO:0033077 |
IGI |
T cell differentiation in thymus |
GO:0038161 |
IDA |
prolactin signaling pathway |
GO:0040014 |
IDA |
regulation of multicellular organism growth |
GO:0040018 |
IGI |
positive regulation of multicellular organism growth |
GO:0042104 |
IGI |
positive regulation of activated T cell proliferation |
GO:0042448 |
IGI |
progesterone metabolic process |
GO:0043029 |
IGI |
T cell homeostasis |
GO:0043066 |
IGI |
negative regulation of apoptotic process |
GO:0045086 |
IGI |
positive regulation of interleukin-2 biosynthetic process |
GO:0045579 |
IGI |
positive regulation of B cell differentiation |
GO:0045588 |
IGI |
positive regulation of gamma-delta T cell differentiation |
GO:0045621 |
IGI |
positive regulation of lymphocyte differentiation |
GO:0045647 |
IGI |
negative regulation of erythrocyte differentiation |
GO:0045931 |
IGI |
positive regulation of mitotic cell cycle |
GO:0045944 |
IGI |
positive regulation of transcription from RNA polymerase II promoter |
GO:0045954 |
IMP |
positive regulation of natural killer cell mediated cytotoxicity |
GO:0046449 |
IMP |
creatinine metabolic process |
GO:0046543 |
IMP |
development of secondary female sexual characteristics |
GO:0046544 |
IGI |
development of secondary male sexual characteristics |
GO:0046983 |
IDA |
protein dimerization activity |
GO:0048541 |
IGI |
Peyer's patch development |
GO:0050729 |
IGI |
positive regulation of inflammatory response |
GO:0060397 |
IDA |
JAK-STAT cascade involved in growth hormone signaling pathway |
GO:0070669 |
IMP |
response to interleukin-2 |
GO:0070670 |
IMP |
response to interleukin-4 |
GO:0070672 |
IMP |
response to interleukin-15 |
GO:0071363 |
IDA |
cellular response to growth factor stimulus |
GO:0071364 |
ISS |
cellular response to epidermal growth factor stimulus |